Michael Mcclellan
Senior Vice President, Interim Chief Financial Off
Dermatology
teva
Belarus
Biography
Michael (Mike) McClellan became Interim Chief Financial Officer on July 1, 2017. For the last two years, Mike has served as the CFO of our Global Specialty Medicines Group (GSM).
Research Interest
Prior to joining Teva, Mike was the U.S. CFO at Sanofi, where his career spanned over 20 years in roles of increasing responsibility in global finance and healthcare with responsibility for financial strategy, shared services, financial reporting, tax, treasury, and compliance. Mike received his BS in Accountancy, as well as a BSBA in Economics from the University of Missouri.
